All posts by imreal

Medical Device Premarket Review Pathways Webinar on August 9, 2022


Medical Device Premarket Review Pathways and

FDA Mechanisms for Expedited Review

An FDAnews Webinar

Tuesday, August 9, 2022, 1:30 p.m. – 3:00 p.m. EDT

https://wcg.swoogo.com/md-premarket-review-pathways

Finding a successful premarket pathway for a medical device can bring effective, crucial treatments to patients at a quicker speed, saving lives and improving symptoms. There are multiple ways to gain a faster review or reach a customer base within an expedited time frame, but none of them are without complexity.

The Medical Device Premarket Review Pathways and FDA Mechanisms for Expedited Review webinar will detail the avenues that devicemakers can take to achieve a successful premarket review from the FDA. Legal and regulatory expert Michael Gaba will share insights into the final guidance from the FDA around the STeP program and how navigating the eligibility criteria and submission requirements differ from those necessary to obtain a Breakthrough Designation. He’ll also discuss specific questions around situations that could arise for an organization jumping into this process, like what to do with two devices that have the same intended use. Finally, he’ll share his thoughts on the current state of the Medical Coverage of Innovative Technology (MCIT) Pathway.

Key webinar takeaways include:


  • FDA Premarket Review Pathways


a. Best practices for interacting with the FDA

b. Criteria and processes for various pathways

c. Submission timing and content requirements for obtaining a designation

d. Eligibility for designation for specific situations, including two devices with the same intended use or combination considerations

  • Breakthrough Device Designation and STeP


a. Criteria for Breakthrough Device Designation

b. Submission timing and content requirements

c. Benefits of breakthrough designation or STeP program inclusion

  • Medical Coverage of Innovative Technology (MCIT) Pathway


a. Updates on the current MCIT program status

b. CMS’ final rule on coverage, repeal of that rule and concerns around the original provisions and plans

c. MCIT connections to the upcoming 21st Century Cures Act

Attend this webinar for insights into which process is best and how to can find success at the end of the journey.

Webinar Details

Medical Device Premarket Review Pathways and

FDA Mechanisms for Expedited Review

An FDAnews Webinar

Tuesday, August 9, 2022, 1:30 p.m. – 3:00 p.m. EDT

https://wcg.swoogo.com/md-premarket-review-pathways

Tuition:

$287

Easy Ways to Order:

Online: https://wcg.swoogo.com/md-premarket-review-pathways

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations.

Share article on social media or email:

Dr. Victoria Veytsman Expands Her Partnership With Exclusive Haute Beauty Network


Dr. Victoria Veytsman

Being able to provide my patients with the best in dental treatment options and patient comfort gives me the greatest pleasure and I consider it my biggest privilege.

Dr. Victoria Veytsman, owner of Cosmetic Dental Studios is one of the premier cosmetic dentists in New York City. Her unique set of technical skills across multiple areas of dentistry along with her compassion and commitment toward patient comfort have allowed her to earn a superlative reputation amongst her patients and colleagues. An artist at heart, Dr. Veytsman has a passion for smile transformations where art and science come together to create healthy, beautiful smiles every day.

Dr. Veytsman is the youngest graduate of New York University College of Dentistry at the age of 22. She completed a residency at St. Lukes-Roosevelt, a Columbia College of Physicians and Surgeons Hospital. She is a graduate of several cosmetic post-graduate programs including The Hornbrook Group for Advanced Clinical Education in San Diego and Dental Aesthetic Masters at the University of Nevada Las Vegas. Dr. Veytsman has trained with some of the world’s best cosmetic dentists at the Nash Institute, the Los Angeles Institute of Esthetic Dentistry, the Center for Esthetic Excellence and completed a two-year fellowship at NYU in dental implantology.

Dr. Veytsman is also involved in a Biotechnology Enterprise program at Johns Hopkins University. She is a fellow of the Academy of Dental Facial Esthetics, a member of the American Academy of Cosmetic Dentistry, The American Dental Association, the International Congress of Oral Implantologists, and the Royal Society of Medicine, UK.

Dr. V started her practice from scratch with the vision of merging health and beauty and having dentistry be a different, fun experience that patients would look forward to. Her private practice is built upon a solid foundation of experience running the gamut from general dentistry, cosmetic and restorative, to implantology and functional aesthetics. She has earned a notable reputation for compassionate care and creating beautiful smiles for adults and teens alike.

Dr. Veytsman’s niche in cosmetic dentistry has led her to create gorgeous smiles for some of the top beauties in New York, which include: The Miss Universe Organization: Miss New York USA, Miss New York Teen USA, The Miss America Organization, Miss New York, Miss New York Latina Organization; multiple New York Cheerleading teams including the Brooklyn Nets and New York Giants; and the lead sponsor of the New York Emmy’s along with celebrities, models and TV personalities. She has been a featured smile expert on WebMD, NewBeauty, Latina Magazine, Brides, Yahoo! Health, Social Life Magazine, Hamptons Magazine, NBC’s The Today Show, and more.

As a native New Yorker, Dr. Veytsman understands the importance of giving back to the community and developed the “smile for a smile” campaign. She is involved with several charities: Operation Smile, the Bowery Mission, Urban Tech, National Hemophilia Foundation, Smile Train, and B4BC.org (Boarding for Breast Cancer). Dr. Veytsman donates 50 percent of all teeth-whitening to B4BC.org in support of programs that educate young women on breast cancer.

“Being able to provide my patients with the best in dental treatment options and patient comfort gives me the greatest pleasure and I consider it my biggest privilege. I enjoy the process of getting to know every individual, taking care of them, and creating customized beautiful and healthy smiles.”

Learn more about Dr. Victoria Veytsman by visiting: https://hauteliving.com/hautebeauty/member/dr-victoria-veytsman/

ABOUT HAUTE BEAUTY NETWORK:

Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.

For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Share article on social media or email:

CPAP Store USA introduces Transcend Micro, world’s smallest, smartest and lightest travel CPAP Machine from Somnetics International


The Somnetics Transcend Micro Smallest Smart Auto Travel CPAP Machine is the smallest and lightest CPAP device available on the market today weighing under 0.5 lbs. and measuring less than 4 inches.

The Somnetics Transcend Micro Smallest Smart Auto Travel CPAP Machine is the smallest and lightest CPAP device available on the market today weighing under 0.5 lbs. and measuring less than 4 inches.

CPAP Store USA, nation’s leading authorized dealer with multi-location concierge brick & mortar store and an e-commerce offering high quality, carefully curated and cost effective sleep apnea therapy products is excited to announce and introduce Transcend Micro Auto Travel CPAP Machine, the world’s smallest, smartest and lightest travel CPAP Machine from Somnetics International, an American medical company who is a recipient of multiple awards including Medtrade and Frost & Sullivan Award

Transcend Micro Auto Travel CPAP Machine is available in United States at CPAPstoreUSA.com and its retail stores including Las Vegas, Nevada; Los Angeles, California and Dallas, Texas.

The Transcend Micro Auto Travel CPAP Machine includes many new digital features designed to make therapy setup and nightly use easier for patients who are on-the-go or during their travels. The baseball-sized travel Transcend Micro CPAP machine features proven algorithms for compact and portable therapy weighing less than 0.5 pounds and measuring under 4 inches.

Patients who rely on humidification can now travel with waterless humidifiers and their TMicro CPAP Machine. Somnetics has taken the portable humidification to a whole new level, preventing patients from carrying distilled water with them to small capsules known as HME’s.

The HME is ideal for dry and high altitude environments where humidity levels are low, e.g., aircraft and to reduce patient’s throat soreness, and prevent dry mouth.

Another remarkable feature that the Transcend Micro offers is the GentleRise technology. It assists patients with falling asleep more comfortably by delivering a lower pressure at the beginning of sleep and increases pressure gradually until reaching its desired level.

The Transcend Micro is also designed with the AirRelief feature to help patients breathe easier and more comfortably while asleep by reducing pressure on exhalation. Unique among travel CPAPs, the Transcend Micro is compatible with any CPAP mask.

“We cater to a large customer base in the United States who trust not only our experts with their knowledge and experience but also the manufactures that CPAP Store USA partners with including an American-based company – Somentics. CPAP store USA strongly believes in supporting and working together with the US companies first prior to partnering with companies overseas.” said Marina BerBeryan, Ambassador of CPAP Store USA. “This is where the joint success is achieved in making a difference in patients lives every day and every night.”

CPAP Store USA is a concierge authorized dealer with multi-location brick & mortar store and an e-commerce that offers patients an expert-led shopping experience tailored to their personal sleep apnea therapy needs including CPAP Machines, BiPAP Machines, CPAP and BiPAP Masks, CPAP and BiPAP Supplies, Oxygen Concentrators and more!

What distinguishes CPAP Store USA apart from other CPAP stores is the online and in-stores personal shopping experience for patients sleep apnea supplies and devices.

Offering a complementary concierge sleep apnea service since 2001, CPAP Store USA’s CPAP Specialists deliver individualized support and service through beginning and/ or to duration of the patients sleep apnea treatment. The concierge services includes …


  • Personalized mask fittings.
  • Purchase guidance on CPAP and BiPAP machines based on their physician recommendations.
  • Customized training on sleep apnea therapy devices and supplies covering the use and maintenance.
  • Six days a week complimentary consultation available in-store with full time Respiratory Therapists and CPAP Specialists.
  • 24/7 assistance available on e-commerce with live CPAP Specialists.
  • Post-purchase technical and customer service support is delivered through digital communication e-mail, e-fax, smart phones text messages, online upload forms, telemedicine and over the phone.

To meet patients expectations and their success in their sleep apnea therapy CPAP store USA, provides unmatched customer support and elevated customer experience from start-to-end of their treatment of Obstructive Sleep Apnea (OSA) and Central Sleep Apnea (CSA).

CPAP Store USA National Locations:

CPAP STORE USA

3325 W Desert Inn Road, Suite 201

Las Vegas, Nevada 89102

https://www.CPAPStoreUSA.com

(888)512-7278

CPAP STORE LAS VEGAS

3325 W Desert Inn Road, Suite 301

Las Vegas, Nevada 89102.

https://www.CPAPStoreLasVegas.com

(800) 479-1308

CPAP STORE LOS ANGELES

1551 N. La Brea Ave, Unit A,

Los Angeles, California, 90028

https://www.CPAPStoreLosAngeles.com

(800) 479-1308

CPAP STORE AGOURA HILLS

5160 Kanan Road

Agoura Hills, California, 91301

https://www.CPAPStoreAgouraHills.com

(888)223-1605

CPAP STORE DALLAS

3920 Rosemeade, Suite 150

Dallas, Texas 75287

https://www.CPAPStoreDallas.com

(800) 598-0524

CPAP STORE DALLAS FORT WORTH

https://www.CPAPStoreDFW.com

(800)940-0327

Follow CPAP Store USA at…

Facebook: @CPAPstoreUSA

Twitter: @CPAPstoreUSA

Instagram: @CPAPstoreUSA

LinkedIn: @CPAPstoreUSA

Google+: @CPAPstoreUSA

Yelp: @CPAPstoreUSA

Hollywood Times PR

Olga Love

Hollywoodtimespr@gmail.com

Share article on social media or email:



US Fertility introduces Embryology Tuition Reimbursement Program in celebration of World Embryologist Day


US Fertility announces a new Embryology Tuition Reimbursement Program in celebration of World Embryologist Day.

“Our incredible embryology team is at the heart of our commitment to driving innovation and improving outcomes for our patients. Through our Embryology Tuition Reimbursement Program, we will support our team members to further their education.”

US Fertility announces a new Embryology Tuition Reimbursement Program in celebration of World Embryologist Day. Through this program, US Fertility increases its commitment to investing in its embryologists personally and professionally.

“US Fertility team members choose to build their career home at US Fertility because of the hope we inspire within our patients, the life we help bring into the world, and the culture of excellence we foster across our partner practices,” shares Michael Tucker, Ph.D., US Fertility Scientific Director. “Our incredible embryology team is at the heart of our commitment to driving innovation and improving outcomes for our patients. Through our Embryology Tuition Reimbursement Program, we will support our team members to further their education so that we can better serve those who are facing infertility.”

The Embryology Tuition Reimbursement Program will reimburse tuition for master’s and doctoral degrees focused on embryology. The program offers up to $25,000 annually in tuition reimbursement for US Fertility employees across its partner practices who have completed 1 year of full-time employment.

US Fertility is the largest network of physician-owned and physician-led fertility practices in the United States. With more than 130,000 babies born to its credit, they complete more than 29,000 IVF cycles annually and perform 1,000+ elective and donor egg freezing cycles annually.

“US Fertility is known as an innovator and leader of reproductive sciences across the country,” shares embryologist Yuri Wagner, senior embryologist at US Fertility partner practice Fertility Centers of Illinois. “We all have one goal in mind — helping our patients achieve their family-building goals. It’s an incredible honor to be a part of that process.”

US Fertility shares a deep commitment to constantly improving the patient experience and pioneering research and development in reproductive medicine. Embryologists across US Fertility have been nationally recognized for their excellence in achieving high success rates, leading to improved outcomes for patients facing infertility.

US Fertility is a national leader offering a range of clinical, administrative, and operations positions available at locations throughout the United States. For more information on open positions, visit the US Fertility careers page.

About US Fertility

US Fertility is the nation’s largest partnership of physician-owned and physician-led top-tier fertility practices in the United States, offering comprehensive fertility-market-focused non-clinical, administrative, and technical platforms that help domestic and international practices improve patient outcomes and increase patient access. To learn more about partnership- or affiliate-status benefits, call 301-545-1308 or visit USFertility.com.

Share article on social media or email:

Parkhurst NuVision To Offer IC-8® Apthera™ Intraocular Lens, the First and Only Small Aperture Lens for Cataract Surgery San Antonio


Clear acrylic award for Dr. Parkhurst after completing the IC-8 study sitting on desk, blurry background

Dr. Parkhurst of Parkhurst NuVision Completed the 2020 IC-8 IOL IDE Study

“We are excited to be part of the clinical investigators for this new lens that will help cataract patients. Parkhurst NuVision is always looking for new innovations for laser eye surgery” said Gregory Parkhurst, MD of Parkhurst NuVision in San Antonio, TX.

The Apthera IOL is the first small aperture IOL to receive FDA approval, the first lens indicated for implantation with a monofocal or monofocal toric IOL in the fellow eye, the first extended depth of focus lens indicated for monovision, and the first non-toric IOL indicated for cataract patients with low amounts of corneal astigmatism.

Cataracts are a common condition affecting an estimated 24 million people in the United States. Cataracts can only be treated with surgery in which the cloudy natural lens is removed and an artificial lens, or IOL is implanted. The Apthera IOL, with its proprietary small aperture technology, seamlessly provides excellent distance vision and clear intermediate and near vision, effectively mitigating the effects of presbyopia.

Parkhurst NuVision was part of the clinical study that evaluated the safety and effectiveness of the Apthera IOL implanted in one eye and a monofocal or monofocal toric IOL implanted in the fellow eye. A total of 453 subjects were enrolled and followed for 12 months. Outcomes for the Apthera IOL group (n=343) were compared to a control group (n=110) receiving a monofocal or monofocal toric IOL in both eyes. Apthera IOL treated eyes maintained 2 D of extended depth of focus and demonstrated 0.91 D of additional range of vision benefit over monofocal IOL eyes at 0.2 logMAR threshold, exceeding the 0.50 D ANSI criterion for extended depth of focus IOLs. Apthera IOL subjects achieved equivalent uncorrected distance vision and statistically superior intermediate and near vision compared to control subjects. Apthera IOL subjects also achieved comparable binocular contrast sensitivity to control subjects in both photopic and mesopic conditions, a first reported for an extended depth of focus lens.

“We are excited to be part of the clinical investigators for this new lens that will help cataract patients. Parkhurst NuVision is always looking for new innovations for laser eye surgery,” said Gregory Parkhurst, MD of Parkhurst NuVision in San Antonio, TX.

Parkhurst NuVision plans to begin use of the Apthera IOL in the U.S. in the fall of 2022 when it becomes commercially available.

ABOUT THE IC-8® APTHERA™ IOL

The IC-8 Apthera IOL is a wavefront-filtering intraocular lens for unilateral implantation in patients who have as much as 1.5 D of corneal astigmatism in the implanted eye. This IOL, compared to a monofocal or monofocal toric IOL, provides an extended range of vision from distance through near. The Apthera IOL is the first extended depth of focus lens indicated for monovision.

As with any cataract surgery, risks of complications exist whether or not the IOL is implanted. The complications of IOL implantation surgery range from minor side effects (usually temporary) to serious complications. A full list of benefits and risks associated with the IC-8 Apthera IOL will be available online and the patient information brochure.

For more information about Apthera IOL or cataract procedures, please contact Parkhurst NuVision at akruse@nuvisiontx.com

Share article on social media or email:

The Middle East and Africa a $4 Billion Hotbed for IVD Investment


“In the IVD industry, emerging markets such as the Middle East and Africa are currently the major source of industry growth.” – Daniel Granderson, associate editor for Kalorama Information.

Globally, in vitro diagnostic (IVD) companies are exploring opportunities in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care. As the COVID-19 dust settles, it is expected that the interest in geographic expansion will once again return to the Middle East and Africa region. This is an important region where the market for in vitro diagnostics reached an estimated $4,126 million ($4.1 billion) in 2021 and is expected to grow 2.2% compounded annually through 2026, according to leading medical market research firm Kalorama Information in the report, In Vitro Diagnostics (IVD) in the Middle East and Africa.

In the Middle East and Africa, lifestyle changes–a more sedentary lifestyle resulting in rising obesity rates–has brought about the emergence of “Western” diseases such as diabetes. Thus, there is growing demand in the region, therefore, for medical tests.

“In the IVD industry, emerging markets are currently the major source of industry growth. Opportunity for innovation, as well, exists in emerging markets, where acceleration of new products is the largest mid- to long-term driver of value,” says Daniel Granderson, associate editor for Kalorama Information.

Major IVD companies have reported growth in Turkey and Saudi Arabia, considered two of the top seven emerging markets. These countries continue to invest in healthcare infrastructure and insurance coverage for a growing and increasingly more affluent middle class.

In developing markets, including those in the Middle East and Africa, with increased demand for healthcare has come increased access to it. In the 1970s, many countries in the Middle East and the Gulf countries started down a path of providing public healthcare to citizens. Countries such as, Oman, Saudi Arabia, Qatar, Iraq, Syria and Turkey all have universal healthcare programs. Much of urban African regions followed closely behind. This development requires increased investment in healthcare. This increased investment most often takes the form of government tenders, which remain a major source of supply for state-controlled labs and hospitals.

IVD manufacturers can expect new availability of tests and test systems designed for use in resource poor settings worldwide; increased consolidation of healthcare services throughout the world, developed and emerging economies included, and thus, increased pricing pressure on all medical devices, including IVDs; and increased availability of healthcare insurance in emerging countries, providing an opportunity for expansion of the IVD market to serve the growth in people who have access to healthcare.

Despite all this interest, investment, and opportunity, the Middle East and Africa still remains an underserved region with large market potential.

About the Report

This new report (published May 2022) provides an overview of developments in the in vitro diagnostics industry in the Middle East and Africa. For more information or to purchase “In Vitro Diagnostics (IVD) in the Middle East and Africa”, visit: https://kaloramainformation.com/product/in-vitro-diagnostics-ivd-in-the-middle-east-and-africa/.

Six segments of the IVD market in the Middle East are examined in the report:


  • Clinical Chemistry
  • Immunoassay
  • Microbiology
  • Point of Care (POC)
  • Histology – traditional stains
  • Other (includes nucleic acid assays, blood bank ABO, sequencing, prenatal tests and other areas not covered specifically in the above segments)

The countries and regions examined in the report include:

  • Egypt
  • Iran
  • Iraq
  • Israel
  • Jordan
  • Saudi Arabia
  • South Africa
  • Turkey
  • United Arab Emirates (UAE)
  • Other Mideast (Bahrain, Cyprus, Gaza Strip, Kuwait, Lebanon, Oman, Qatar, Syria, West Bank, Yemen)
  • Other Africa (Algeria, Congo, Sudan, Libya, Chad, Niger, Angola, Mali, Ethiopia, etc.)

Share article on social media or email:

Mindray To Showcase Innovative Vascular Imaging Technologies At SVU 2022


Mindray Vascular Imaging

Mindray invites all SVU attendees to visit booth #301-303 to connect with the Mindray team and explore innovative vascular ultrasound solutions, including the latest technological advancements in color and Doppler sensitivity, penetration, workflow enhancement tools, and ergonomics.

Mindray, a global leader and developer of healthcare technologies and solutions for ultrasound, patient monitoring, and anesthesia, announced they are returning to the show floor in Lake Buena Vista, FL, for the Society for Vascular Ultrasound (SVU) Annual Conference, August 4 – 6. All SVU attendees are invited to visit Mindray booth #301-303 to connect with the Mindray team and explore innovative vascular ultrasound solutions, including the latest technological advancements in color and Doppler sensitivity, penetration, workflow enhancement tools, and ergonomics.

On display, Mindray will have their premium Resona 7 Lightning Edition and Resona I9 Ultrasound Systems. The Resona 7 Ultrasound System Lightning Edition delivers crystal clear and uniform imaging for vascular exams. It provides the details needed for a confident diagnosis without the need for additional imaging modalities. The Resona I9 Ultrasound breaks the mold of conventional ultrasound systems to provide an entirely new experience driven by innovation. Powered by Mindray’s revolutionary ZONE Sonography® Technology+ (ZST+), the Resona I9 System boasts advanced ultrasound capabilities that provide a harmonic balance of resolution and tissue uniformity.

“We are very excited to debut live vascular scanning with our Resona I9 in addition to our premium flagship Resona 7 Lightning Ultrasound at SVU this year,” said Michelle Carter, Marketing Manager, Radiology Ultrasound. Carter continued, “Seeing is believing – we welcome visitors to stop by our live displays to discuss and inquire about these revolutionary ultrasound systems that are changing the face of healthcare as we know it.”

Mindray’s Tools for Vascular Diagnostic Imaging:

  • HD Scope: A proprietary image processing technique that enhances B-mode tissue characterization improves resolution in a specific region of interest.
  • Sound Speed Compensation (SSC): Automatically detects and analyzes different tissue characteristics to determine the optimal signal speed needed for improved image quality.
  • RIMT: An advanced image processing technique that analyzes the received channel data in unique ways and applies filtering and processing algorithms to achieve more optimal resolution for various tissue types.
  • R-VQS: Based on Radio Frequency data, this technology provides an extremely accurate calculation of vessel wall distension and real-time auto measurement for six cardiac cycles.
  • V-Flow: Creates a quantitative vector map representing the true hemodynamic states produced by red blood cells as they traverse through a vessel, allowing for rapid data analysis and post-processing manipulation.
  • Glazing Flow: Provides optimal visualization of micro-vascular perfusion states and improves delineation of vessel borders in an intuitive, 3D visualization technology.

Mindray Vascular Publications and Events

  • Journal of Diagnostic Medical Sonography (JDMS): Carotid Plaque Characterization Using Quantitative Shear Wave Elastography. Authored by Jim Baun BS, RDMS, RVT, FSDMS, Educational Consultant, Michelle Carter, MBA, RDMS, RVT, RDCS, Mindray North America Marketing Manager, Radiology Ultrasound, and Todd Hall, BS, RVT, RPhS, Mindray North America Clinical Technology Specialist and former Technical Director at The Vascular Center at Mercy Medical Center. Mindray has confirmed that Michelle and Todd will attend SVU to discuss the study and any questions.
  • Vascular CME Webinar: Mindray is hosting a free vascular CME event on August 25th. This webinar will highlight three topics in vascular ultrasound: visceral duplex ultrasound, jugular vein anatomy and evaluation, and transcranial Doppler ultrasound. Presenting on these topics will be – Laurie Lozanski, BS, RVS, RVT, Todd Hall, BS, RVT, RPhS, and Jason Williams, RDMS, RVS, RCS.

Mindray’s ultrasound solutions command a powerful return on investment by offering the industry’s best investment protection and total cost of ownership. The Resona 7 Lightning and Resona I9 are backed by Mindray’s exclusive Living Technology™ promise, providing customers with easily upgraded software enhancements to secure product investment protection. Mindray developed this program to help equip their partners and clinicians with ultrasound solutions they won’t soon outgrow. This allows Mindray to continue innovating, evolving, and enhancing their ultrasound solutions while ensuring their customers can remain at the cutting edge of imaging performance excellence – free of charge.

Mindray invites all SVU attendees to stop by booth #301-303 and see how innovative, cost-effective, leading-edge ultrasound solutions can empower your Vascular Department to provide the highest quality of care now and in the future.

About Mindray

Mindray is a leading developer, manufacturer, and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: patient monitoring and life support, in-vitro diagnostics, and medical imaging. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in San Jose, California with additional facilities in major international markets around the world. For more information, please visit http://www.mindray.com

Share article on social media or email:

Workout Anytime Launches Ad Partnership with 5460: The Joe West Podcast


Workout Anytime, a leader in fitness franchising with nearly 190 units open across the U.S., has announced a new ad partnership with 5460: The Joe West Podcast, a weekly program covering the life and career of retired MLB umpire “Cowboy” Joe West.

Through the partnership, Workout Anytime will sponsor 5460, featuring ads promoting the brand’s industry-leading franchise opportunity, voiced by West and co-host Mike Claiborne.

“We are huge fans of 5460 and Joe West, and we are always looking for new ways to reach audiences who may not yet be aware of our franchise opportunity, so this is a perfect fit for us,” said Terri Harof, Director of Franchise Sales. “This partnership will allow us to put our opportunity in front of like-minded entrepreneurs who will help fuel the brand’s growth.”

Named for the number of games umpired in Major League Baseball by West (an all-time record), 5460 is hosted by veteran sports broadcaster Mike Claiborne and features guests including Mark Grace, Eduardo Perez, Jerry Reinsdorf, Joe Buck, Larry Gatlin and Charles Barkley. The podcast dives deep into West’s career, which saw some of the most iconic moments in baseball history, including Nolan Ryan’s 5th career no-hitter, Willie McCovey’s 500th home run and Felix Hernandez’s perfect game in 2012.

Earlier this year, Workout Anytime signed a 20-unit deal, putting the 189-unit franchise on track to cross the milestone 200-unit mark before the end of 2022.

5460: The Joe West podcast releases episodes every Monday and is available through all major podcast platforms, including Apple Music and Spotify. You can also find the podcast at PodcastHeat.com.

The startup costs for a Workout Anytime franchise range from $562,850 to $1,008,550, including the franchisee fee. To learn more about franchising with Workout Anytime, visit https://workoutanytimefranchise.com/.

ABOUT WORKOUT ANYTIME:

Atlanta-based Workout Anytime is a 24-hour, seven-day-a-week fitness concept with nearly 190 units across the U.S. Founded by fitness veterans John Quattrocchi and Steve Strickland, the company was formed to provide members with first-class fitness facilities at the lowest cost possible while delivering a profitable and affordable business model to franchisees. Built on the founders’ motto of “think big, keep it simple and do it with integrity,” Workout Anytime is preparing for significant expansion into new territories across the U.S. and Central America by providing opportunities to business-minded entrepreneurs. Franchise opportunities are available, and more information can be found on http://workoutanytimefranchise.com/.

Share article on social media or email:

Suburban Laboratories Lose Luster As Life Sciences Seek Urban Settings


Joseph Simone at Hutchinson Metro Center overlooking site of campus expansion

“Even in New Jersey—which boasts considerable life sciences laboratories in suburban settings—there is movement toward urban cores,” said Joe Simone, President of Simone Development Companies.

Suburban research laboratories face increasing competition from urban centers as proximity to talent and capital drive life science companies’ site-location choices, said Joseph Simone of Simone Development Companies.

“Even in New Jersey—which boasts considerable life sciences laboratories in suburban settings—there is movement toward urban cores,” said Joe Simone, President of Simone Development Companies. “In Jersey City’s Exchange Place neighborhood, a former Palmolive factory has been converted into a 340,000-square-foot lab-ready office building that is a short ferry ride to Manhattan’s Financial District.”

A recent report noted that life science companies are flocking to New York City because of its research hospitals, universities, and venture capital. This urban migration is also driven by the search for top talent, which increasingly prefers to live and work in urban environments offering easy access to diverse cultural, entertainment and retail experiences — qualities that many suburban laboratories can’t match.

One of New York City’s innovation clusters is in the Bronx’s Morris Park neighborhood, where the Montefiore-Einstein Accelerated Biotechnology Research Center will soon open. This biomanufacturing operation will focus on cell, gene, and antibody therapy production.

Simone Development Companies’ 42-acre Hutchinson Metro Center is across the street from the Albert Einstein College and Montefiore Medical Center. The campus is anchored by Montefiore, which occupies the entirety of Tower Two and parts of Tower One.

As in the case of the new Jersey City complex, knowledge workers and other talent in Manhattan can reach the Montefiore-Einstein Accelerated Biotechnology Research Center by public transportation. With the anticipated commuter rail station next to the Hutchinson Metro Center, knowledge workers will enjoy a short train ride to Manhattan’s Penn Station.

“Life-science start-ups are making strategic decisions to settle near the talent and financiers who want to be in big cities. Our planned expansion of the Hutchinson Metro Center to include lab-ready offices is a response to the latest needs of medical research and technology development,” said Patricia Simone, Principal and President of the Simone Management Group.

Simone Development Companies is a full-service real estate investment company specializing in the acquisition and development of healthcare, mixed-use, office, industrial, retail and residential properties. Headquartered at the Hutchinson Metro Center, it boasts a portfolio of over 7 million square feet throughout the Bronx, Manhattan, Queens, Long Island, Westchester County, Orange and Fairfield Counties and New Jersey. With services spanning acquisition, development, construction, finance, asset management, accounting, leasing and property management, Simone Development Companies is set apart by its vertically integrated management team, long-term asset ownership and its pursuit of visionary development.

Share article on social media or email:

Brady’s Wraptor A6200 Wrap Printer Applicator Now in Stock at Heilind Electronics


Brady’s Wraptor A6200 Wrap Printer Applicator saves time and labor with a one-step print-and-apply process.

Heilind Electronics, an authorized distributor for Brady and a premier distributor of electronic components worldwide, is now stocking Brady’s Wraptor A6200 Wrap Printer Applicator.

A compact and lightweight printer applicator, the Wraptor A6200 is designed for flexible work environments like cellular manufacturing. Its compact design moves easily to different workstations and takes up minimal space, which allows more room to work — and ultimately, to increase productivity.

With Brady’s automated Wraptor A6200 Wrap Printer Applicator, printing and wrapping is completed in less than seven seconds. This process eliminates expensive and time-consuming hand labeling, reducing print and wrap cycle time by 50 percent relative to hand application.

Each unit features a diverse set of connection options, including ports for USB, Wi-Fi, and Ethernet. Typical print throughput is up to 1000 labels per day at 300 dpi. This versatile printer is used in sectors like contract manufacturing and logistics for the identification of products, distribution facilities, electronic components, and wires.

Visit Heilind’s website for more information about Brady’s Wraptor A6200 Wrap Printer Applicator.

About Heilind Electronics

Heilind Electronics, Inc. (https://www.heilind.com) is one of the world’s leading distributors of connectors, relays, sensors, switches, thermal management and circuit protection products, terminal blocks, wire and cable, wiring accessories, and insulation and identification products. Founded in 1974, Heilind has locations throughout the U.S., Canada, Mexico, Brazil, Germany, Singapore, Hong Kong, and China.

About Brady Corporation

Brady Corporation is an international manufacturer of high-performance labels, signs, safety devices, printing systems, and software. Founded in 1914, the company has a diverse customer base in electronics, telecommunications, manufacturing, electrical systems, construction, medicine, aerospace, and a variety of other industries.

Share article on social media or email: